Browsing: SIB

Top Line: Can FDG-PET be used to dose-escalate the primary tumor when treating locally advanced head and neck cancer?The Study:…

Simultaneously boosting intraprostatic disease is becoming increasingly common, and so is the need to accurately identify and delineate intraprostatic disease.…

pHART2-RCT was an oddly named, but pragmatic randomized, phase 2 trial that compared simultaneous, moderately hypofractionated and sequential, conventionally fractionated…

Top Line: Can a simultaneous integrated boost approach be used for post-operative treatment of soft tissue sarcoma?The Study: Post-operative radiation…

The FLAME trial showed that focal boost to MRI-defined intraprostatic disease improved DFS in patients with intermediate and high risk…